If I was investing in a small/medium-cap as a promising manufacturer of 'anns' (announcements to the ASX), then yes, AHZ doesn't produce timely and stimulating anns in the way that some do.
Happily, I invest in AHZ because of their product line, both on the shelf and potential.
I am reminded of another biotech Stirling (STI). Ah, now there was a robust manufacturer of anns for you, so many of them too good to be true.
In fact, they weren't true, but hey, they were really great anns.
tongue-in-cheek.
DYOR
Goodnight all.
P.
I disclose buckets of AHZ.
and no, I never bought into STI
AHZ Price at posting:
17.5¢ Sentiment: LT Buy Disclosure: Held
